News

Research May 2 2025 2025-05-02

A study involving IDIBAPS-Hospital Clínic reveals how stellate cells regulate liver metabolism and regeneration

Hepatic stellate cells are responsible for producing fibrosis in the liver. Under normal conditions, these cells remain dormant, but when liver tissu1

Research March 31 2022 2022-03-31

Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer

A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1

Research January 28 2022 2022-01-26

Prophylactic transfusions of blood products do not prevent bleeding following endoscopic treatment of oesophageal varices in patients with cirrhosis

This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeutic1

Research April 8 2021 2021-04-13

Factors related to improvement are established in patients with alcoholic liver cirrhosis on a transplant waiting list

A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with a1